NA
ZVRA icon

NewEdge Advisors’s Zevra Therapeutics ZVRA Stock Holding History

NewEdge Advisors’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.3K Hold
4,000
– – ﹤0.01% 3018
2025
Q4 		$35.8K Sell
4,000
-18,338
-82% -$173K ﹤0.01% 3058
2025
Q3 		$212K Buy
22,338
+18,338
+458% +$184K ﹤0.01% 2381
2025
Q2 		$35.2K Hold
4,000
– – ﹤0.01% 2767
2025
Q1 		$30K Hold
4,000
– – ﹤0.01% 2724
2024
Q4 		$33.4K Hold
4,000
– – ﹤0.01% 2658
2024
Q3 		$27.8K Hold
4,000
– – ﹤0.01% 2621
2024
Q2 		$19.6K Sell
4,000
-24
-0.6% -$114 ﹤0.01% 2634
2024
Q1 		$23.3K Sell
4,024
-450
-10% -$2.77K ﹤0.01% 2582
2023
Q4 		$29.3K Sell
4,474
-426
-9% -$1.99K ﹤0.01% 2423
2023
Q3 		$23.6K Hold
4,900
– – ﹤0.01% 2340
2023
Q2 		$25K Sell
4,900
-300
-6% -$1.62K ﹤0.01% 2313
2023
Q1 		$28.6K Sell
5,200
-1,000
-16% -$5.29K ﹤0.01% 2218
2022
Q4 		$4.61K Buy
+6,200
New +$31.5K ﹤0.01% 2623

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return